PASCAL: Predicting Cerebrovascular Adverse Events Post Cardiac Surgery

Sponsor
IRCCS Policlinico S. Donato (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05786274
Collaborator
University of Milan (Other)
104
1
1
36
2.9

Study Details

Study Description

Brief Summary

The aims of this study are: i) to assess cerebral autoregulation and autonomic control within the different phases of cardiac surgery with cardiopulmonary bypass; ii) to compare cerebral autoregulation measures derived via cerebral blood flow velocity estimated by transcranial Doppler device with simpler measurements derived from near infrared spectroscopy; iii) to develop a predictive model of postoperative cerebrovascular outcome (overt or silent stroke) based on the extracted indices.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Cerebral autoregulation monitoring
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
104 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Predicting Cerebrovascular Adverse Events Post Cardiac Surgery With Cardiopulmonary Bypass by Means of Cerebral AutoreguLation Indices
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Mar 31, 2026
Anticipated Study Completion Date :
Mar 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Other: Cardiac surgery with cardiopulmonary bypass patients

Patients will be enrolled before cardiac surgery with cardiopulmonary bypass (CPB) and monitored until after the surgery. Patients enrolled will undergo diffusion weighted magnetic resonance imaging and will be administered with cognitive tests one day before surgery and within one week after surgery. Cerebral blood flow velocity as derived from transcranial Doppler recordings will be acquired from the middle cerebral artery synchronously with arterial pressure, invasively derived from the radial artery, and with the electrocardiogram as derived from patient's monitor. Signals will be acquired before anesthesia induction (BASAL), after anesthesia induction and intubation of the chest (ANESTH) and during CPB (CPB). Each acquisition will last at least 5 minutes and will be prolonged to the maximum possible length in keeping with clinical scheduling. Partial pressure of carbon dioxide and other clinical parameters will be acquired too during the intervention.

Diagnostic Test: Cerebral autoregulation monitoring
Perioperative characterization of cerebral autoregulation and autonomic function; characterization of adverse events after surgery

Outcome Measures

Primary Outcome Measures

  1. Cerebral autoregulation during cardiac surgery with cardiopulmonary bypass [36 months]

    to assess cerebral autoregulation and autonomic control within the different phases of the intervention

  2. Comparison of cerebral autoregulation measures derived from transcranial Doppler device and near infrared spectroscopy [36 months]

    to compare cerebral autoregulation measures derived via cerebral blood flow velocity estimated by transcranial Doppler device with simpler measurements derived from near infrared spectroscopy

  3. Predictive model of postoperative cerebrovascular outcome [36 months]

    to develop a predictive model of postoperative cerebrovascular outcome based on cerebral autoregulation and autonomic function indices

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age older than 18 years

  • spontaneous sinus rhythm

  • no pregnancy

  • signed informed consent

Exclusion Criteria:
  • age lower than 18 years

  • absence of sinus rhythm

  • autonomic disorders

  • concomitant carotid intervention

  • reintervention

  • contraindication to MRI

  • pregnancy

  • impossibility of informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vlasta Bari San Donato Milanese Milan Italy 20097

Sponsors and Collaborators

  • IRCCS Policlinico S. Donato
  • University of Milan

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Vlasta Bari, Principal Investigator, IRCCS Policlinico S. Donato
ClinicalTrials.gov Identifier:
NCT05786274
Other Study ID Numbers:
  • PASCAL
  • GR-2021-12372037
First Posted:
Mar 27, 2023
Last Update Posted:
Mar 27, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Vlasta Bari, Principal Investigator, IRCCS Policlinico S. Donato
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 27, 2023